Novel 3-substituted fluorine imidazolium/triazolium salt derivatives: synthesis and antitumor activity

jinmei liu,min wang,yunjing zhou,juming yan,lijuan yang,yan li,hongbin zhang,xiaodong yang
DOI: https://doi.org/10.1039/c5ra07947k
IF: 4.036
2015-01-01
RSC Advances
Abstract:A series of novel (+/-)-3-substituted fluorene-imidazolium/triazolium salt derivatives has been prepared and evaluated in vitro against a panel of human tumor cell lines. The results suggest that the existence of 2-methyl-benzimidazole or 5,6-dimethyl-benzimidazole rings and substitution of the imidazolyl/triazolyl3/4-position with a naphthylacyl or 4-methoxyphenacyl group were important for modulating cytotoxic activity. Compounds 37 and 42 were found to be the most potent derivatives with IC50 values of 0.51-2.51 mu M and exhibited cytotoxic activities selectively against myeloid leukaemia (HL-60), liver carcinoma (SMMC-7721) and lung carcinoma (A549). Compound 37 can remarkably induce the G2/M phase cell cycle arrest and apoptosis in SMMC-7721 cells. Additionally, compound 30 exhibited selective cytotoxicity to some extent between cancer cells (A549) and normal cells (BEAS-2B).
What problem does this paper attempt to address?